These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20629082)

  • 1. First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer.
    Dwivedi RC; St Rose S; Roe JW; Chisholm E; Elmiyeh B; Nutting CM; Clarke PM; Kerawala CJ; Rhys-Evans PH; Harrington KJ; Kazi R
    Head Neck; 2011 Mar; 33(3):341-8. PubMed ID: 20629082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech and voice outcomes in oropharyngeal cancer and evaluation of the University of Washington Quality of Life speech domain.
    Thomas L; Jones TM; Tandon S; Carding P; Lowe D; Rogers S
    Clin Otolaryngol; 2009 Feb; 34(1):34-42. PubMed ID: 19260883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients' complaints.
    Rinkel RN; Verdonck-de Leeuw IM; van Reij EJ; Aaronson NK; Leemans CR
    Head Neck; 2008 Jul; 30(7):868-74. PubMed ID: 18302270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients.
    Dwivedi RC; St Rose S; Chisholm EJ; Bisase B; Amen F; Nutting CM; Clarke PM; Kerawala CJ; Rhys-Evans PH; Harrington KJ; Kazi R
    Oral Oncol; 2012 Jun; 48(6):547-53. PubMed ID: 22289636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of functioning in patients with head and neck cancer according to the International Classification of Functioning, Disability, and Health (ICF): a multicenter study.
    Tschiesner U; Linseisen E; Baumann S; Siedek V; Stelter K; Berghaus A; Cieza A
    Laryngoscope; 2009 May; 119(5):915-23. PubMed ID: 19358200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A UK multi-centre pilot study of speech and swallowing outcomes following head and neck cancer.
    Radford K; Woods H; Lowe D; Rogers SN
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):376-81. PubMed ID: 15270826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidisciplinary head and neck cancer clinic and adherence with speech pathology.
    Starmer H; Sanguineti G; Marur S; Gourin CG
    Laryngoscope; 2011 Oct; 121(10):2131-5. PubMed ID: 21826674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French version of Speech Handicap Index: validation and comparison with the Voice Handicap Index.
    Degroote G; Simon J; Borel S; Crevier-Buchman L
    Folia Phoniatr Logop; 2012; 64(1):20-5. PubMed ID: 21734397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy.
    Kazi R; Singh A; De Cordova J; Al-Mutairy A; Clarke P; Nutting C; Rhys-Evans P; Harrington K
    Clin Otolaryngol; 2006 Oct; 31(5):404-10. PubMed ID: 17014450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers.
    Dwivedi RC; Kazi RA; Agrawal N; Nutting CM; Clarke PM; Kerawala CJ; Rhys-Evans PH; Harrington KJ
    Cancer Treat Rev; 2009 Aug; 35(5):417-24. PubMed ID: 19481871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Validation and Reliability of the Chinese Version of the Speech Handicap Index for Patients With Oral and Oropharyngeal Cancer.
    Li T; Ma L; Mao C
    J Voice; 2016 Mar; 30(2):247.e23-31. PubMed ID: 25817541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
    Jensen K; Bonde Jensen A; Grau C
    Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
    Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
    Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quality of life in patients treated for cancer of paranasal sinus and other area at head and neck].
    Strek P; Oleś K; Składzień J; Tomik J; Gajec S; Kocoń S; Dutsch-Wicherek M; Hartwich P; Szaleniec J
    Przegl Lek; 2010; 67(12):1298-301. PubMed ID: 21591356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity.
    List MA; D'Antonio LL; Cella DF; Siston A; Mumby P; Haraf D; Vokes E
    Cancer; 1996 Jun; 77(11):2294-301. PubMed ID: 8635098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective acoustic-phonetic speech analysis in patients treated for oral or oropharyngeal cancer.
    de Bruijn MJ; ten Bosch L; Kuik DJ; Quené H; Langendijk JA; Leemans CR; Verdonck-de Leeuw IM
    Folia Phoniatr Logop; 2009; 61(3):180-7. PubMed ID: 19571552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the French Versions of the Speech Handicap Index and the Phonation Handicap Index in Patients Treated for Cancer of the Oral Cavity or Oropharynx.
    Balaguer M; Farinas J; Fichaux-Bourin P; Puech M; Pinquier J; Woisard V
    Folia Phoniatr Logop; 2020; 72(6):464-477. PubMed ID: 31734664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term quality of life after total laryngectomy.
    Vilaseca I; Chen AY; Backscheider AG
    Head Neck; 2006 Apr; 28(4):313-20. PubMed ID: 16200627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI; Arias F; Tejedor M; Pruja E; Marcos M; Martínez E; Valerdi J
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.